Fundraising FoxSamsara
Boston, US · 8 known investors
Find your way into Samsara
Sign up to see every warm intro you have to Samsara
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Samsara team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.
Investors · 8
Apollo Health Ventures✓ confirmed by SamsaraBerlin
How we know: the company's own site · Not right? Tell us
Andreessen HorowitzreportedMenlo Park · $500K – $50M
How we know: company funding news (hacker news) · samsara.com · Not right? Tell us
Gen.GreportedSeoul
How we know: a partner's Signal profile · Not right? Tell us
.png)
Frequently asked questions
- What does Samsara do?
- Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.
- Who are Samsara's investors?
- Samsara's investors include Apollo Health Ventures, AHO Beratung Gmb H, CoastCap, FJ Labs, Korify Capital, Andreessen Horowitz, Gen.G, General Catalyst.
- Where is Samsara headquartered?
- Samsara is headquartered in Boston, US.